Ivan A. Derkachev

111 A, Kievskaya Str
Tomsk, TOM 634012, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Opioids regulate the functional state of immune cells and reduce inflammatory cardiac injury: Role of opioid receptors, MRGPRX2, and TLR4.

Opioids regulate the functional state of immune cells and reduce inflammatory cardiac injury: Role of opioid receptors, MRGPRX2, and TLR4.

Journal: Journal of biomedical research

Published: November 06, 2025

The role of adrenergic receptors and sex steroid hormones in takotsubo syndrome.

The role of adrenergic receptors and sex steroid hormones in takotsubo syndrome.

Journal: Physiology international

Published: September 16, 2025

Infarct-Limiting Efficacy of the μ2‑Opioid Receptor Peptide Agonist Endomorphin‑1 in Metabolic Syndrome and Aging.

Infarct-Limiting Efficacy of the μ2‑Opioid Receptor Peptide Agonist Endomorphin‑1 in Metabolic Syndrome and Aging.

Journal: Bulletin of experimental biology and medicine

Published: August 18, 2025

Metabolic syndrome reduces but does not eliminate the cardioprotective effect of adaptation to hypoxia: the link with changes in the opioid system.

Metabolic syndrome reduces but does not eliminate the cardioprotective effect of adaptation to hypoxia: the link with changes in the opioid system.

Journal: Pflugers Archiv : European journal of physiology

Published: June 18, 2025

Intra-myocardial hemorrhage and cardiac microvascular injury in ischemia/reperfusion. A systematic review of current evidences.

Intra-myocardial hemorrhage and cardiac microvascular injury in ischemia/reperfusion. A systematic review of current evidences.

Journal: Current problems in cardiology

Published: September 23, 2024

Do platelets protect the heart against ischemia/reperfusion injury or exacerbate cardiac ischemia/reperfusion injury? The role of PDGF, VEGF, and PAF.

Do platelets protect the heart against ischemia/reperfusion injury or exacerbate cardiac ischemia/reperfusion injury? The role of PDGF, VEGF, and PAF.

Journal: Life sciences

Published: January 25, 2024

The role of β-adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β-adrenergic receptor agonists and antagonists protect the heart?

The role of β-adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β-adrenergic receptor agonists and antagonists protect the heart?

Journal: Fundamental & clinical pharmacology

Published: October 13, 2023

A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena.

A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena.

Journal: Journal of biomedical research

Published: July 28, 2023

The β2-adrenergic receptor agonist formoterol attenuates necrosis and apoptosis in the rat myocardium under experimental stress-induced cardiac injury.

The β2-adrenergic receptor agonist formoterol attenuates necrosis and apoptosis in the rat myocardium under experimental stress-induced cardiac injury.

Journal: Fundamental & clinical pharmacology

Published: July 12, 2023

Angiotensin 1-7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart-The signaling mechanism.

Angiotensin 1-7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart-The signaling mechanism.

Journal: Fundamental & clinical pharmacology

Published: June 29, 2023

The effect of an adaptation to hypoxia on cardiac tolerance to ischemia/reperfusion.

The effect of an adaptation to hypoxia on cardiac tolerance to ischemia/reperfusion.

Journal: Journal of biomedical research

Published: May 15, 2023

KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury.

KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury.

Journal: Fundamental & clinical pharmacology

Published: February 27, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026